Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38239047)

  • 1. Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.
    Tantawy MN; McIntyre JO; Yull F; Calcutt MW; Koktysh DS; Wilson AJ; Zu Z; Nyman J; Rhoades J; Peterson TE; Colvin D; McCawley LJ; Rook JM; Fingleton B; Crispens MA; Alvarez RD; Gore JC
    Cancer Med; 2024 Feb; 13(3):e6812. PubMed ID: 38239047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
    Felix DD; Gore JC; Yankeelov TE; Peterson TE; Barnes S; Whisenant J; Weis J; Shoukouhi S; Virostko J; Nickels M; McIntyre JO; Sanders M; Abramson V; Tantawy MN
    Nucl Med Biol; 2015 Mar; 42(3):269-73. PubMed ID: 25533764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.
    Wilson GH; Gore JC; Yankeelov TE; Barnes S; Peterson TE; True JM; Shokouhi S; McIntyre JO; Sanders M; Abramson V; Ngyuen TQ; Mahadevan-Jansen A; Tantawy MN
    J Nucl Med; 2014 Jul; 55(7):1138-43. PubMed ID: 24833491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
    Hoffmann E; Schache D; Höltke C; Soltwisch J; Niland S; Krähling T; Bergander K; Grewer M; Geyer C; Groeneweg L; Eble JA; Vogl T; Roth J; Heindel W; Maus B; Helfen A; Faber C; Wildgruber M; Gerwing M; Hoerr V
    J Transl Med; 2023 Aug; 21(1):577. PubMed ID: 37641066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
    Wu F; Chen Y; Li D; Wang Z; Yu M
    Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
    McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
    J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.
    Longo DL; Bartoli A; Consolino L; Bardini P; Arena F; Schwaiger M; Aime S
    Cancer Res; 2016 Nov; 76(22):6463-6470. PubMed ID: 27651313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer Tumor pH Imaging.
    Dhakan C; Anemone A; Ventura V; Carella A; Corrado A; Pirotta E; Villano D; Romdhane F; Gammaraccio F; Aime S; Longo DL
    Metabolites; 2023 Nov; 13(11):. PubMed ID: 37999256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models.
    Irrera P; Consolino L; Roberto M; Capozza M; Dhakan C; Carella A; Corrado A; Villano D; Anemone A; Navarro-Tableros V; Bracesco M; Dastrù W; Aime S; Longo DL
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
    Rousseau C; Ruellan AL; Bernardeau K; Kraeber-Bodéré F; Gouard S; Loussouarn D; Saï-Maurel C; Faivre-Chauvet A; Wijdenes J; Barbet J; Gaschet J; Chérel M; Davodeau F
    EJNMMI Res; 2011 Sep; 1(1):20. PubMed ID: 22214534
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
    Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive
    Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
    J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer.
    Li Z; Belitzky E; Blaha O; Cavaliere A; Katz SR; Aboian M; Melegari L; Rajabimoghadam K; Kurpiewski S; Zhu X; Marquez-Nostra B
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.